These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1391 related articles for article (PubMed ID: 12949498)

  • 1. Signalling pathways of the TNF superfamily: a double-edged sword.
    Aggarwal BB
    Nat Rev Immunol; 2003 Sep; 3(9):745-56. PubMed ID: 12949498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphotoxin/light, lymphoid microenvironments and autoimmune disease.
    Gommerman JL; Browning JL
    Nat Rev Immunol; 2003 Aug; 3(8):642-55. PubMed ID: 12974479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The TNF-TNF receptor system.
    Hehlgans T; Männel DN
    Biol Chem; 2002 Oct; 383(10):1581-5. PubMed ID: 12452434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What does tumour necrosis factor excess do to the immune system long term?
    Clark J; Vagenas P; Panesar M; Cope AP
    Ann Rheum Dis; 2005 Nov; 64 Suppl 4(Suppl 4):iv70-6. PubMed ID: 16239393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TNF alpha acting on TNFR1 promotes breast cancer growth via p42/P44 MAPK, JNK, Akt and NF-kappa B-dependent pathways.
    Rivas MA; Carnevale RP; Proietti CJ; Rosemblit C; Beguelin W; Salatino M; Charreau EH; Frahm I; Sapia S; Brouckaert P; Elizalde PV; Schillaci R
    Exp Cell Res; 2008 Feb; 314(3):509-29. PubMed ID: 18061162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactivation of TNF signaling by rationally designed dominant-negative TNF variants.
    Steed PM; Tansey MG; Zalevsky J; Zhukovsky EA; Desjarlais JR; Szymkowski DE; Abbott C; Carmichael D; Chan C; Cherry L; Cheung P; Chirino AJ; Chung HH; Doberstein SK; Eivazi A; Filikov AV; Gao SX; Hubert RS; Hwang M; Hyun L; Kashi S; Kim A; Kim E; Kung J; Martinez SP; Muchhal US; Nguyen DH; O'Brien C; O'Keefe D; Singer K; Vafa O; Vielmetter J; Yoder SC; Dahiyat BI
    Science; 2003 Sep; 301(5641):1895-8. PubMed ID: 14512626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and function of TNF family member B cell-activating factor in the development of autoimmune arthritis.
    Zhang M; Ko KH; Lam QL; Lo CK; Srivastava G; Zheng B; Lau YL; Lu L
    Int Immunol; 2005 Aug; 17(8):1081-92. PubMed ID: 16000326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor necrosis factor, lymphotoxin and cancer.
    Drutskaya MS; Efimov GA; Kruglov AA; Kuprash DV; Nedospasov SA
    IUBMB Life; 2010 Apr; 62(4):283-9. PubMed ID: 20155809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Network communications: lymphotoxins, LIGHT, and TNF.
    Ware CF
    Annu Rev Immunol; 2005; 23():787-819. PubMed ID: 15771586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel function of TNF cytokines in regulating bone marrow B cell survival.
    Zhang M; Ko KH; Lam QL; Lo CK; Xu DJ; Shen L; Zheng B; Srivastava G; Lu L
    Cell Mol Immunol; 2004 Dec; 1(6):447-53. PubMed ID: 16293214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TNF-mediated inflammatory disease.
    Bradley JR
    J Pathol; 2008 Jan; 214(2):149-60. PubMed ID: 18161752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reverse signalling of membrane-integrated tumour necrosis factor differentially regulates alloresponses of CD4+ and CD8+ T cells against human microvascular endothelial cells.
    Vudattu NK; Holler E; Ewing P; Schulz U; Haffner S; Burger V; Kirchner S; Andreesen R; Eissner G
    Immunology; 2005 Aug; 115(4):536-43. PubMed ID: 16011522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokine pattern determines the progression of experimental periodontal disease induced by Actinobacillus actinomycetemcomitans through the modulation of MMPs, RANKL, and their physiological inhibitors.
    Garlet GP; Cardoso CR; Silva TA; Ferreira BR; Avila-Campos MJ; Cunha FQ; Silva JS
    Oral Microbiol Immunol; 2006 Feb; 21(1):12-20. PubMed ID: 16390336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The uncertain glory of APRIL.
    Medema JP; Planelles-Carazo L; Hardenberg G; Hahne M
    Cell Death Differ; 2003 Oct; 10(10):1121-5. PubMed ID: 14502235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LIGHT (TNFSF14), a novel mediator of bone resorption, is elevated in rheumatoid arthritis.
    Edwards JR; Sun SG; Locklin R; Shipman CM; Adamopoulos IE; Athanasou NA; Sabokbar A
    Arthritis Rheum; 2006 May; 54(5):1451-62. PubMed ID: 16649193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TNF ligands and receptors in autoimmunity: an update.
    Mackay F; Kalled SL
    Curr Opin Immunol; 2002 Dec; 14(6):783-90. PubMed ID: 12413530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphotoxin alpha 1 beta 2: a critical mediator in V alpha 14i NKT cell differentiation.
    Franki AS; Van Beneden K; Dewint P; Meeus I; Veys E; Deforce D; Elewaut D
    Mol Immunol; 2005 Feb; 42(4):413-7. PubMed ID: 15607792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An APRIL to remember: novel TNF ligands as therapeutic targets.
    Dillon SR; Gross JA; Ansell SM; Novak AJ
    Nat Rev Drug Discov; 2006 Mar; 5(3):235-46. PubMed ID: 16474316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topoisomerase inhibitor camptothecin sensitizes mouse hepatocytes in vitro and in vivo to TNF-mediated apoptosis.
    Hentze H; Latta M; Künstle G; Dhakshinamoorthy S; Ng PY; Porter AG; Wendel A
    Hepatology; 2004 May; 39(5):1311-20. PubMed ID: 15122760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double knockout mice show BASH and PKCdelta have different epistatic relationships in B cell maturation and CD40-mediated activation.
    Nojima T; Hayashi K; Goitsuka R; Nakayama K; Nakayama K; Kitamura D
    Immunol Lett; 2006 May; 105(1):48-54. PubMed ID: 16481047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 70.